Should I Buy CCLD? CCLD 2026 Analysis

Should You Buy CareCloud Inc (CCLD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

2.770

1 Day change

-3.48%

52 Week Range

4.750

Analysis Updated At

2026/01/28

Not a good buy right now for a Beginner long-term investor who is impatient. The technical trend is still weak (bearish MACD expansion, price below/near pivot), there are no near-term catalysts in the news, and the latest quarter shows revenue growth but sharply weaker earnings. Despite one bullish analyst initiation, overall setup doesn’t yet justify deploying $50k–$100k aggressively at this moment.

Technical Analysis

Price is 2.855 (-1.55%) and sitting right on key support S1=2.851, below the pivot 2.942 (near-term bearish/weak). RSI(6)=37.1 is neutral-to-soft (not oversold enough to signal a strong rebound). MACD histogram is slightly negative and expanding lower, indicating downside momentum is still building. Moving averages are converging, suggesting consolidation, but with momentum currently favoring sellers. Near-term levels: support 2.851 then 2.795; resistance 3.033 then 3.089. Intellectia Proprietary Trading Signals: - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock recently.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

Open interest put/call ratio at 0.48 suggests positioning is more call-heavy (mildly bullish longer-horizon positioning). However, today’s volume put/call ratio at 4.0 (puts dominating) signals bearish/defensive near-term sentiment. Total options volume is low (25 contracts) but is elevated vs average, and implied volatility is very high (30D IV ~100%), implying the market is pricing large moves and uncertainty rather than a calm bullish trend.

Technical Summary

Sell

Buy

Positive Catalysts

Revenue grew +8.83% YoY in 2025/Q3, showing the top line is still expanding.
ThinkEquity initiated coverage with a Buy and an $8 price target (bullish sell-side catalyst).
Price is sitting on a defined support level (2.851), which sometimes triggers technical bounces.

Neutral/Negative Catalysts

Momentum is currently bearish: MACD is negative and worsening; price is below the pivot (2.942).
No supportive news flow in the last week (no visible event-driven catalyst).
Options trading sentiment is bearish near-term (put volume dominates).
Profitability trend weakened materially in the latest quarter (net income and EPS down sharply YoY).

Financial Performance

Latest quarter: 2025/Q3. Revenue rose to 31.07M (+8.83% YoY), and gross margin improved to 34.83 (+0.58 YoY), which is constructive. However, net income fell to 1.695M (-354.12% YoY) and EPS fell to 0.04 (-200% YoY), indicating earnings power deteriorated meaningfully despite revenue growth—an unfavorable combination for a long-term, beginner-friendly buy decision right now.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: mixed-to-improving but not unanimously bullish. Roth Capital kept a Neutral rating while raising its price target to $3.25 from $2.25 after Q3, citing cost controls but also a flattening revenue/EBITDA outlook (cautious). ThinkEquity later initiated with a Buy and an $8 target (bullish). Wall Street pros/cons: Pros—potential upside if execution and profitability improve (as implied by the $8 initiation). Cons—another major firm remains Neutral and highlights limited growth visibility; current price action and earnings trend don’t yet confirm a durable turnaround. Hedge funds/insiders: both neutral with no significant recent trends. Politicians/congress: no recent congress trading data available (no notable political trading signal).

3 Analyst Rating

Wall Street analysts forecast CCLD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCLD is 6.42 USD with a low forecast of 3.25 USD and a high forecast of 8 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

1 Hold

0 Sell

Moderate Buy

Current: 2.870

Low

3.25

Averages

6.42

High

Current: 2.870

Low

3.25

Averages

6.42

High

ThinkEquity

NULL -> Buy

initiated

AI Analysis

2025-11-24

Reason

ThinkEquity

Price Target

AI Analysis

2025-11-24

initiated

NULL -> Buy

Reason

ThinkEquity initiated coverage of CareCloud with a Buy rating and $8 price target.

Roth Capital

Richard Baldry

Neutral

upgrade

2025-11-06

Reason

Roth Capital

Richard Baldry

Price Target

2025-11-06

upgrade

Neutral

Reason

Roth Capital analyst Richard Baldry raised the firm's price target on CareCloud to $3.25 from $2.25 and keeps a Neutral rating on the shares. The firm upped estimates post the Q3 report. Cost controls and cuts will extend CareCloud's adjusted EBITDA in the near-term, the analyst tells investors in a research note. Roth cites the company's "flattening" revenue and EBITDA outlook for its hold rating.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CCLD

Unlock Now

CCLD Should I Buy

CCLD Should I Buy

Should You Buy CareCloud Inc (CCLD) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch